About usThe Medical Oncology department aims to development new diagnostic tools and treatments in order to improve the life expectancy of cancer patients, while preserving a good quality of life. Our research focuses on immunotherapy, translational medical oncology and experimental clinical research.
ScreenPoint Medical raises $28 million for further developmentSeries C funding led by Insight Partners2 August 2021
Sonlicromanol seems promising for certain cancersKhondrion announces publication in PLOS ONE of new research13 July 2021
Cognitive behavioral therapy reduces severe fatiguein patients with advanced cancer during treatment28 January 2020